Literature DB >> 25141539

Suppression of Eis and expression of Wag31 and GroES in Mycobacterium tuberculosis cytosol under anaerobic culture conditions.

Vineet K Maurya, Kavita Singh, Sudhir Sinha.   

Abstract

A major impediment in chemotherapy of Tuberculosis (TB) is the persistence of M. tuberculosis in a latent or dormant state, possibly perpetuated by paucity of oxygen within the lung granuloma. Proteome analysis of the anaerobically persisting microbe could therefore provide novel targets for drugs against latent TB infection (LTBI). An Indian clinical isolate of M. tuberculosis was cultured under aerobic and anaerobic conditions following Wayne's hypoxia model and its cytosolic proteins were resolved by two-dimensional gel electrophoresis (2DE). Peptide mass fingerprinting of 32 differentially expressed spots using MALDI TOF-TOF MS-MS resulted in identification of 23 proteins. Under the anaerobic culture conditions, expression of 12 of these proteins was highly suppressed (>2 fold reduction in spot volumes), with 4 of them (GrpE, CanB, MoxR1 and Eis) appearing as completely suppressed since corresponding spots were not detectable in the anaerobic sample. On the other hand, 4 proteins were highly expressed, with two of them (Wag31 and GroES) being uniquely expressed under anaerobic conditions. Suppression of Eis could make the anaerobically persisting bacilli susceptible to the aminoglycoside antibiotics which are known to be acetylated and inactivated by Eis. Although all 4 overexpressed proteins can be considered as putative drug targets for LTBI, Wag31 appears particularly interesting in view of its role in the cell wall biogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25141539

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  4 in total

1.  Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis.

Authors:  A Aggarwal; R Gupta; V S Negi; L Rajasekhar; R Misra; P Singh; V Chaturvedi; S Sinha
Journal:  Clin Exp Immunol       Date:  2017-02-23       Impact factor: 4.330

2.  Cytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MS.

Authors:  Divakar Sharma; Manju Lata; Rananjay Singh; Nirmala Deo; Krishnamurthy Venkatesan; Deepa Bisht
Journal:  Front Microbiol       Date:  2016-11-15       Impact factor: 5.640

3.  Identification of Mycobacterium tuberculosis Peptides in Serum Extracellular Vesicles from Persons with Latent Tuberculosis Infection.

Authors:  Carolina Mehaffy; Nicole A Kruh-Garcia; Barbara Graham; Leah G Jarlsberg; Charis E Willyerd; Andrey Borisov; Timothy R Sterling; Payam Nahid; Karen M Dobos
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

4.  Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain.

Authors:  Angkanang Sowajassatakul; Therdsak Prammananan; Angkana Chaiprasert; Saranya Phunpruch
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-07-16       Impact factor: 3.944

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.